Make it more than a pipe-dream for NanoBioTix, a 'PipeLines of Promise' competitor


Jorge Boczkowski - Mécanismes fondamentaux de la... by nanomedTV


Of those whose works I follow which balance out the doom-and-gloom domain that can be nanotoxicity and nanopathogenesis, Dr. Laurent Lévy, PhD is one of the most sincere of nanomedicine researchers. Emphasising the medicine as much as the method, his nanoradiotherapeutics / nanotheragnostics team genuinely pursues its corporate aims while adhering to the principal precepts of the Corpus Hippocraticum maxim (Epidemics I.11)

"As to diseases, make a habit of two things — to help, or at least to do no harm."


Dr. Lévy is CEO of Nanobiotix® © - the translational, pioneering, SUNY at Buffalo spin-off which is devoted to revolutionising localised cancer treatment. Not engaging in the nanotech trend simply for novelty's sake, Nanobiotix® © incorporated existing standard radiation equipment while developing innovative radiotherapeutics products  based on high-energy physical mechanisms of actions which improve tumour control.


Nanobiotix® © is where the rubber meets the road in radiotherapy and it needs our votes as the favoured biotech company in the Buzz of BIO's Pipelines of Promise contest category at the BIO International Convention to rev up its development.

If the winner, Nanobiotix® © will garner complimentary Full Convention Access with Partnering. It may be selected to receive a free Company Presentation in the BIO Business Forum where Dr. Lévy and his group can demonstrate the worth of their intellectual capital.  

CLICK HERE TO VOTE

{One vote per person, per category}.

Voting closes on 30 April 2012.

http://www.laurentlevy.com/

http://www.nanobiotix.com/about-us/

DISCLOSURE: This blogger holds no position in nor possesses ties to Nanobiotix® © - financially, professionally, or personally - and derives no direct or indirect benefit therefrom.

Views: 58

Tags: Jorge_Boczkowski, Laurent_Lévy, Nanobiotix, critical_care_medicine, medical_physics, nano-IRT, nano-oncology, nanomédecine, nanotherapeutics, nanoxray, More…radio-isotopes, radionuclides, radiotherapy, toxicité_des_nanoparticules_manufacturées

Comment

You need to be a member of The International NanoScience Community to add comments!

Join The International NanoScience Community

Welcome - about us

Welcome! Nanopaprika was cooked up by Hungarian chemistry PhD student in 2007. The main idea was to create something more personal than the other nano networks already on the Internet. Community is open to everyone from post-doctorial researchers and professors to students everywhere.

There is only one important assumption: you have to be interested in nano!

Nanopaprika is always looking for new partners, if you have any idea, contact me at editor@nanopaprika.eu

Dr. András Paszternák, founder of Nanopaprika

Publications by A. Paszternák:

Smartphone-Based Extension of the Curcumin/Cellophane pH Sensing Method

Pd/Ni Synergestic Activity for Hydrogen Oxidation Reaction in Alkaline Conditions

The potential use of cellophane test strips for the quick determination of food colours

pH and CO2 Sensing by Curcumin-Coloured Cellophane Test Strip

Polymeric Honeycombs Decorated by Nickel Nanoparticles

Directed Deposition of Nickel Nanoparticles Using Self-Assembled Organic Template,

Organometallic deposition of ultrasmooth nanoscale Ni film,

Zigzag-shaped nickel nanowires via organometallic template-free route

Surface analytical characterization of passive iron surface modified by alkyl-phosphonic acid layers

Atomic Force Microscopy Studies of Alkyl-Phosphonate SAMs on Mica

Amorphous iron formation due to low energy heavy ion implantation in evaporated 57Fe thin films

Surface modification of passive iron by alkylphosphonic acid layers

Formation and structure of alkylphosphonic acid layers on passive iron

Structure of the nonionic surfactant triethoxy monooctylether C8E3 adsorbed at the free water surface, as seen from surface tension measurements and Monte Carlo simulations

Next partner events of TINC

We are Media Partner of: